Androgen News and Research

RSS
Researchers discover unexpected role for the clock gene in prostate cancer progression

Researchers discover unexpected role for the clock gene in prostate cancer progression

Inflammation marker linked to increased fatigue in prostate cancer patients treated with ADT

Inflammation marker linked to increased fatigue in prostate cancer patients treated with ADT

Researchers have a promising lead on COVID-19 treatment

Researchers have a promising lead on COVID-19 treatment

FDA approves first oral drug for treating adult patients with advanced prostate cancer

FDA approves first oral drug for treating adult patients with advanced prostate cancer

Low testosterone can increase risk of severe COVID-19 in males

Low testosterone can increase risk of severe COVID-19 in males

CRYM protein counteracts the growth of prostate tumors

CRYM protein counteracts the growth of prostate tumors

Gene signature may help develop new therapies against advanced prostate cancer

Gene signature may help develop new therapies against advanced prostate cancer

Two paralogous androgen receptor genes control social dominance

Two paralogous androgen receptor genes control social dominance

Reducing the airborne transmission risk for SARS-CoV-2

Reducing the airborne transmission risk for SARS-CoV-2

Researchers identify a novel vulnerability in advanced prostate cancer

Researchers identify a novel vulnerability in advanced prostate cancer

Researchers report outcomes of salvage low dose RT brachytherapy after EBRT for prostate cancer

Researchers report outcomes of salvage low dose RT brachytherapy after EBRT for prostate cancer

Androgen deprivation strategies could help mitigate SARS-CoV-2 infection

Androgen deprivation strategies could help mitigate SARS-CoV-2 infection

A global review of COVID-19 impact on cancer treatment and research

A global review of COVID-19 impact on cancer treatment and research

Gut bacteria may play a role in prostate cancer therapies

Gut bacteria may play a role in prostate cancer therapies

UTHSC professor receives $455,000 grant to study cause of aggressive prostate cancer

UTHSC professor receives $455,000 grant to study cause of aggressive prostate cancer

Enzalutamide has added benefit for men with castration-resistant prostate cancer at high risk of metastasis

Enzalutamide has added benefit for men with castration-resistant prostate cancer at high risk of metastasis

Radiation therapy delay for prostate cancer patients offers room for flexibility during the pandemic

Radiation therapy delay for prostate cancer patients offers room for flexibility during the pandemic

Darolutamide shows indication of considerable added benefit in prostate cancer

Darolutamide shows indication of considerable added benefit in prostate cancer

Study shows moderate exercise reduces side effects of prostate cancer treatment

Study shows moderate exercise reduces side effects of prostate cancer treatment

Gene signature explains why 18F-FDG imaging performs better for PSMA-suppressed prostate cancer patients

Gene signature explains why 18F-FDG imaging performs better for PSMA-suppressed prostate cancer patients